All News
Filter News
Found 809,065 articles
-
Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights
5/14/2019
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”) today reported financial results for the first quarter ended March 31, 2019 and provided an update on recent operational highlights.
-
BIOGEN’S SPINRAZA® (NUSINERSEN) RECEIVES POSITIVE RECOMMENDATION FROM NICE FOR FUNDING IN THE UNITED KINGDOM FOR THE TREATMENT OF INFANTS, CHILDREN AND ADULTS WITH SPINAL MUSCULAR ATROPHY
5/14/2019
Biogen Inc. (Nasdaq: BIIB) today announced that The National Institute for Health and Care Excellence (NICE) in the United Kingdom has recommended funding for SPINRAZA (nusinersen) on the National Health Service (NHS).
-
AJMC® Study Finds Removing Cost Sharing in Primary Care Reduces Cost, Emergency Visits
5/14/2019
When a large national employer removed cost sharing for primary care visits, medical utilization fell, as did monthly costs, driven mostly by reduced emergency department (ED) visits.
-
Novus Therapeutics Reports First Quarter 2019 Financial Results
5/14/2019
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced financial results for the quarter ended March 31, 2019.
-
Neuralstem Reports First Quarter 2019 Fiscal Results
5/14/2019
Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule compound technologies, reported its financial results for the first quarter ended March 31, 2019.
-
LifeNet Health unveils Center of Excellence for research in San Diego
5/14/2019
LifeNet Health, the world's leading provider of regenerative medicine solutions, today announced the opening of a San Diego facility that stands as a Center of Excellence for its life sciences and tissue-engineering programs, as well as a logistical hub for hospital and surgeon clients on the West Coast.
-
Andrew Pecora, MD, FACP, CPE named CEO of Outcomes Matter Innovations, LLC
5/14/2019
Andrew Pecora, MD, FACP, CPE, has been named chief executive officer (CEO) of Outcomes Matter Innovations, (OMI) LLC, it was announced today.
-
Addus HomeCare To Participate In 2019 RBC Capital Markets Global Healthcare Conference
5/14/2019
Addus HomeCare Corporation (Nasdaq: ADUS), a provider of comprehensive home care services, today announced that Dirk Allison, President and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the 2019 RBC Capital Markets Global Healthcare Conference
-
New BIO Report: More Progress Needed in Innovation of Alzheimer’s Disease Therapeutics
5/14/2019
Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s Disease Therapeutics, the fourth in a series on the innovation landscape of highly prevalent, chronic diseases.
-
National Geographic Announces Keegan-Michael Key as Host of Brain Games
5/14/2019
National Geographic announced today that it has tapped Keegan-Michael Key (“Friends From College,” “Toy Story 4,” “Lion King”) as host of its rebooted hit series Brain Games.
-
FDA warns manufacturers of products labeled as homeopathic for putting consumers at risk with significant violations of manufacturing quality standards
5/14/2019
The U.S. Food and Drug Administration has posted warning letters to five companies who produce products labeled as homeopathic for significant violations of current good manufacturing practice (CGMP) regulations.
-
Stealth BioTherapeutics to Present at UBS Global Healthcare Conference
5/14/2019
Stealth BioTherapeutics (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy, CEO, will present at the UBS Global Healthcare Conference in New York on Tuesday, May 21st 2019, at 2:30pm ET.
-
FDA grants clearance for a heart murmur detection solution on a personal mobile device
5/14/2019
- eMurmur® today announced that its flagship "eMurmur ID" solution has received FDA clearance, enabling a new era in heart murmur detection. eMurmur ID is a mobile and cloud solution which operates in conjunction with a 3rd party electronic stethoscope.
-
Hyperemesis Gravidarum Awareness Day (HGAD) is May 15
5/14/2019
HG Awareness Day is an international event to increase awareness of the pregnancy disease called hyperemesis gravidarum (HG)
-
IQVIA to Host Financial Analyst and Investor Conference on June 18, 2019
5/14/2019
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will host an Analyst and Investor Conference in New York City on Tuesday, June 18, 2019. Management will provide an update on the business, with presentations starting at 9:00 a.m. ET and concluding at approximately 1:00 p.m. ET.
-
Liht Cannabis Corp. Announces First Product Sales and Closing of First Tranche of Private Placement
5/14/2019
Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) ("Liht" or the "Company"), a licensed cannabis cultivator and producer, is pleased to announce that it has commenced its first commercial sales of recreational cannabis in the state of Nevada
-
Surgical Notes Enters Into Transcription Integration Collaboration With HSTpathways
5/14/2019
Surgical Notes, a nationwide provider of revenue cycle services and solutions for the ambulatory surgery center (ASC) and surgical hospital markets, announces it has entered into a collaboration with HSTpathways, a nationwide provider of cloud-based, ASC management software.
-
Exelixis Announces Webcasts of Investor Conference Presentations on May 21, 2019
5/14/2019
Exelixis, Inc. (Nasdaq: EXEL) today announced that the company will be presenting at the following two investor conferences on Tuesday, May 21, 2019, in New York:
-
SoCalBio Announces Regional BioGENEius Student Challenge Winner for Bioscience Innovation
5/14/2019
The Southern California Biomedical Council (SoCalBio), the trade association for the bioscience and digital health industries in Greater Los Angeles, today announced its selection of Nadia Ansari, a 9th-grade student at Sage High School in Newport Coast (Orange County, CA), as winner of the 2019 Southern California BioGENEius Challenge.
-
CEL-SCI Corporation Reports Second Quarter Fiscal 2019 Financial Results
5/14/2019
CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended March 31, 2019.